Key result
ApoE epsilon 4 and epsilon 2 alleles are linked to significantly higher ischemic heart disease risk.
Case-Control (n=685)
Answers are grounded in this paper and cite their sources.
Shows elevated apolipoprotein E ε2 and ε4 allele frequencies in patients with ischemic heart disease, suggesting distinct lipid disorder links.
It has been demonstrated that the genetic polymorphism of apolipoprotein (apo) E is associated with atherosclerosis. Thus, in this study, we have examined the apo E allele frequencies in 109 patients with ischemic heart disease (IHD) and 576 Japanese people as controls, and we have compared these frequencies between patients with IHD and controls. The frequencies of the epsilon 2 and epsilon 4 alleles were significantly higher in patients with IHD than in the controls (epsilon 2: 8.2% vs 3.7%, epsilon 4: 17.0% vs 11.7%), whereas the frequency of the epsilon 3 allele was significantly lower in patients with IHD than in the controls (74.8% vs 84.6%). The epsilon 2-carrying patients with IHD were characterized by type III (43.8%) and IV (25.0%) hyperlipoproteinemia (HLP), whereas the epsilon 4-carrying patients with IHD were characterized by hypercholesterolemia (type IIb HLP: 42.8%, type IIa HLP: 28.6%). It is concluded that both epsilon 2 and epsilon 4 alleles are more associated with IHD than the epsilon 3 allele.
No takes yet. Share an insight, caveat, or question.
Eto et al. (1989) conducted a case-control in Ischemic heart disease (n=685). Apolipoprotein E polymorphism (epsilon 2 and epsilon 4 alleles) vs. Healthy Japanese controls / epsilon 3 allele was evaluated on Apolipoprotein E epsilon 4 allele frequency. Apolipoprotein epsilon 2 and epsilon 4 alleles were more frequent in ischemic heart disease patients than in controls.
Synapse has enriched 10 related papers. Consider them for comparative context: